A novel Immunotherapy Combination in relapsed/refractory Multiple Myeloma: Updated Analysis of Phase 1b Data for Talquetamab, a GPRC5DxCD3 bispecific Antibody, in Combination with Daratumumab

被引：0

作者：

Kortuem, K. M. ^{[1
]}

Bahlis, N. ^{[2
]}

Mateos, M. -V. ^{[3
]}

Weisel, K. ^{[4
]}

Dholaria, B. ^{[5
]}

Garfall, A. ^{[6
]}

Goldschmidt, H. ^{[7
,8
]}

Martin, T. ^{[9
]}

Morillo, D. ^{[10
]}

Reece, D. ^{[11
]}

Hurd, D. ^{[12
]}

Rodriguez-Otero, P. ^{[13
]}

Bhutani, M. ^{[14
]}

D'Souza, A. ^{[15
]}

Oriol, A. ^{[16
,17
,18
]}

Askari, E. ^{[19
]}

San-Miguel, J. ^{[20
]}

van de Donk, N. ^{[21
]}

Vishwamitra, D. ^{[22
]}

Lin, Wang S. X. ^{[22
]}

Prior, T. ^{[22
]}

Vandenberk, L. ^{[23
]}

Smit, Damiette M. -A. ^{[24
]}

Goldberg, J. ^{[25
]}

Waesch, R. ^{[26
]}

Chari, A. ^{[27
]}

机构：

[1] Univ Klinikum Wurzburg, Med Klin 2, Wurzburg, Germany

[2] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[3] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[4] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[6] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[7] Univ Hosp Heidelberg, Internal Med, Heidelberg, Germany

[8] Natl Ctr Tumor Dis, Heidelberg, Germany

[9] Univ Calif San Francisco, San Francisco, CA 94143 USA

[10] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[11] Princess Margaret Canc Ctr, Toronto, ON, Canada

[12] Wake Forest Univ, Ctr Comprehens Canc, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27101 USA

[13] Clin Univ Navarra, Navarra, Spain

[14] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[15] Med Coll Wisconsin, Milwaukee, WI USA

[16] Inst Catala Oncol, Badalona, Spain

[17] Inst Josep Carreras, Badalona, Spain

[18] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[19] Fdn Jimenez Diaz Univ Hosp, Dept Hematol, Madrid, Spain

[20] Clin Univ Navarra, CCUN, CIMA, CIBERONC,IDISNA, Pamplona, Spain

[21] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands

[22] Janssen Res & Dev, Spring House, PA USA

[23] Janssen Res & Dev, Beerse, Belgium

[24] Janssen Res & Dev, Los Angeles, CA USA

[25] Janssen Res & Dev, Raritan, NJ USA

[26] Univ Freiburg, Freiburg, Germany

[27] Mt Sinai Sch Med, New York, NY USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P431

引用

页码：144 / 145

页数：2